1. Introduction
===============

Probiotics are special microorganisms with important characteristics. They can tolerate bile salts and stomach acidity. These microorganisms can be a part of the gut microflora with ability to bind to intestinal cells in competition with pathogen microorganisms. They can produce antimicrobial compounds such as lactic acid, and bacteriocin etc. ([@b1-epj-10-6548]). The term of probiotic is derived from Greek language meaning life. According to the latest report of the Food and Agriculture Organization (FAO) and World Health Organization (WHO), probiotics are live microorganisms whose adequate intake causes beneficial effects on health ([@b2-epj-10-6548]). Several studies demonstrated their effects on prevention and treatment of many diseases ([@b1-epj-10-6548]). Intestinal microflora is very dependent on consumed food type. Therefore, it can substitute harmful microorganisms with useful types. Probiotics promote the growth of beneficial intestinal bacteria or reduce harmful microorganisms ([@b3-epj-10-6548]). Diarrhea is one of the causes of children's illness, and mortality in developing countries. After viruses, bacteria are the second causative agents in diarrhea. Almost 30% of cases are bacterial with high treatment costs, *E. coli* is one of the main bacteria of intestinal microflora ([@b4-epj-10-6548]). Intestinal pathogenic *E. coli* causes 8--10% of diarrhea cases in children ([@b5-epj-10-6548]). Isolation of *E. coli O157:H7* is more than other enteric pathogens especially Shigella in the United States ([@b6-epj-10-6548]). The *Enterohemorrhagic Escherichia coli* (EHEC) strains are discussed as causative agents of hemorrhagic colitis and hemolytic uremic syndrome. Shiga-like toxin of this strain has verotoxic effects. Infective dose of *E. coli O157:H7* is low and up to 100 bacteria causing disease ([@b7-epj-10-6548]). Recently, unprecedented outbreaks of *E. coli O157:H7* infection happened in Japan, Scotland and America and with other serotypes of EHEC in Europe and Australia, it seems, further investigation in applying new techniques to prevent and control these bacteria are necessary ([@b8-epj-10-6548]). In developing countries, as a major public health problem the main cause of diarrhea among children is *Escherichia coli* bacteria ([@b9-epj-10-6548]). Nowadays, probiotics are consumed to inhibit pathogens and increase shelf life of foods. They release antimicrobial compounds (such as lactic acid, bacteriocin and hydrogen peroxide) and compete with pathogens that lead to increase the immune response of the host ([@b1-epj-10-6548]). Incidence of antibiotic resistance, loss of normal intestinal flora, verotoxin induced by *E. coli* strains particularly as a result of taking antibiotics, needs novel therapeutic methods ([@b10-epj-10-6548]). The aim of this study was to determine the antimicrobial effect of different isolated probiotics against *E. coli O157:H7* and pathogenic EHEC strains using two disk diffusion and well diffusion methods.

2. Material and Methods
=======================

2.1. Isolation and identification of bacteria
---------------------------------------------

For separation of probiotic bacteria, 20 samples of traditional dairy products including (yogurt, cheese and milk) and 20 samples of vegetables including carrots and cabbages (red and white) were collected from different areas of Ahvaz city as well as 10 samples of Tarkhineh (traditional food rich of variety of specific probiotics) that were collected from Khorramabad (West of Iran). MRS Broth and MRS Agar mediums (Merck, Germany) were used for their separation of prepared samples. At first 1 gr of each sample (dairy, vegetables, Tarkhineh) (carrots and cabbage samples were crushed in a sterile mortar) were weighed, dissolved in 10 ml MRS Broth medium then incubated at 37 °C and shaken at 140 rpm for 24 hours ([@b8-epj-10-6548]). Serial dilution was prepared (to 10--3) and further purification was performed under sterile conditions by culturing in MRS Agar medium. All isolated colonies were identified using biochemical tests (gram staining, catalase test, oxidase test, growth at different temperatures and carbohydrates fermentations and motility) and molecular assessment (polymerase chain reaction test) ([@b11-epj-10-6548]). General primers capable proliferations of 16 rRNA genes were used to perform PCR test (Takapoozist, Iran). Primer's sequencing was shown in [Table 1](#t1-epj-10-6548){ref-type="table"}. To confirm genome replication and determine fragment size, PCR protocol was followed on agarose gel. Gel extraction kit was used for extraction 1500-bp single bands. To determine sequencing, purified genes were sent to Takapoozist Company. The results were arranged using BioEdit software and were evaluated in the National Center for Biotechnology Information (NCBI) website using Blast software. Phylogenetic trees of identified isolates were drawn using mega-4 software.

2.2. Supernatant preparing of bacteria
--------------------------------------

After isolation and molecular identification of isolates, 5 strains of probiotic bacteria were selected, randomly. All selected isolates were cultured in MRS Broth and incubated at 37 °C for 24 hours to obtain 0.5 McFarland turbidity (1.5×10^8^ cfu/ml). Bacterial supernatant was prepared by centrifuge of isolates culture suspension for 25 min at 4 °C and 3500 rpm.

2.3. Preparation of pathogenic bacteria
---------------------------------------

Two pathogenic strains of *E. coli* including EHEC (Enterohemorrhagic *E. coli*) and *E. coli* O157:H7 strains were provided by the microbiology department of Tarbiat Modares University in Tehran. TSB medium was used for culturing strains at 37 °C.

2.4. Evaluation of antimicrobial activity of probiotic bacteria
---------------------------------------------------------------

Mueller-Hinton Agar (MHA) was used to investigate antimicrobial activity of isolated probiotic bacteria. For this purpose, inhibitory and antagonistic effects of probiotic bacteria on 2 pathotype of *E. coli* was determined using two methods: Disk Diffusion Agar and Well Diffusion Agar methods. All tests were repeated twice.

### 2.4.1. Disk Diffusion Agar method

Sterile blank disks (8 mm diameter) were smeared with supernatant of 5 probiotic bacteria for 5 minutes. In order to dry them, all disks were placed at 37 °C for 15 minutes. The suspension of pathogenic bacteria was spread on plates containing MHA medium. Impregnated discs with supernatant were placed on MHA with a 2.5 cm distance. All plates were incubated at 37 °C and after 24 hours, growth inhibition zone of probiotics against pathotypes of *E. coli* were measured by a ruler.

### 2.4.2. Well Diffusion Agar method

Suspension of pathogen bacteria cultured in TSB were spread on plates containing MHA, then 10μl of each probiotic supernatant was spilled to punch wells in the plates. After incubation at 37 °C for 24 hours, growth inhibition zone was measured ([@b12-epj-10-6548]). In comparison, antimicrobial effects of 5 antibiotics on 4 pathotype *E. coli* were investigated including: nalidixic acid, penicillin, cephalosporin, gentamicin and novobiocin. For this purpose, the suspension of pathogenic bacteria was spread on TSA plates and antibiotic discs were placed with a distance (2.5 cm) on them. After incubation at 37 °C for 24 hours, growth inhibition zone was measured with a ruler.

3. Results
==========

A total of 13 probiotic colonies isolated from samples of which, 5 isolates were selected to evaluate the antimicrobial effect against 4 *E. coli* pathotypes, randomly, that were subjected to biochemical and molecular identification. Identified probiotics strains were Lactobacillus plantarum, Lactobacillus Gasseri, Enterococcus faecium, Bacillus subtilis, Weissella paramesenteroides. Obtained results showed growth inhibition effects of all 5 probiotic strains on *E. coli* O157:H7 in both used methods. Growth inhibition zone was not seen against EHEC Pathotype in both methods. Mean growth inhibition zone of 5 probiotic strain against *E. coli* O157:H7 pathotype in disk diffusion and well diffusion methods were 9--12 mm and 6--9 mm, respectively. In comparison, inhibition zones in disk diffusion were considerable. Results of growth inhibition zone of two disk diffusion and well diffusion methods were shown in [Tables 2](#t2-epj-10-6548){ref-type="table"} and [3](#t3-epj-10-6548){ref-type="table"}, respectively. Among five probiotic strains, Lactobacillus plantarum and Weissella paramesenteroides created growth inhibition zone in both methods against *E. coli* O157:H7 strain ([Figure 1](#f1-epj-10-6548){ref-type="fig"}). [Table 4](#t4-epj-10-6548){ref-type="table"} shows growth inhibition zone of used antibiotics against two pathotypes. Obtained results showed that nalidixic acid antibiotic had a significant inhibitory effect on both pathotypes EHEC (20 mm) and O157:H7 (22 mm) ([Figure 1](#f1-epj-10-6548){ref-type="fig"}).

4. Discussion and conclusions
=============================

Selected probiotics particularly Lactobacillus plantarum and Weissella paramesenteroides had good inhibitory effects against *E. coli* O157:H7 pathotype. Probiotics had no inhibitory effect on the EHEC strain. Infectious diarrhea diseases are characterized as the second cause of death in children younger than 5 years among infectious diseases ([@b13-epj-10-6548]). Approximately one billion cases of diarrhea occur in children younger than 5 years, annually, of which around 4.5 million lose their lives. Many studies have been conducted to evaluate pathogens causing diarrhea, as well as innovative and effective treatment methods worldwide. Comparing the results, shows variable incidences in different regions. Acute infectious diarrhea is the fifth cause of death and 16.2% of infectious diseases in Iran ([@b14-epj-10-6548]). The fifth cause of acute infectious diarrhea that can lead to death due to infectious diseases in Iran accounted for 16.2 percent of the data ([@b18-epj-10-6548]). Causes of diarrheal diseases are varied between developing and developed countries, considerably -in range. Viruses are important agents of diarrheal diseases in developed countries, while bacterial agents such as ETEC, Campylobacter species, Shigella and Salmonella spp are causing agents in most developing countries ([@b15-epj-10-6548], [@b16-epj-10-6548]). Diarrheagenic *E. coli* is known as the most important causative agent of endemic and epidemic diarrhea in the world ([@b17-epj-10-6548]). Zeighami et al. and Pourakbari et al. recorded that EHEC strain is the causative agent in 12.1 % and 17 % of diarrheal diseases in children younger than 5 years, respectively ([@b18-epj-10-6548],[@b19-epj-10-6548]). Erdogan et al. in Turkey, reported *E. coli* O157:H7 in 1% of diarrheal patients ([@b10-epj-10-6548]). Many studies showed growth inhibitory effects of probiotics against different pathogens, Ota et al. reported that yogurt consumption causes intestinal colonization of probiotic bacteria such as Lactobacillus, and provided conditions to prevent colonization of EHEC. They observed that different lactobacilli culture supernatant can prevent growth of different pathogens such as Listeria monocytogenes, Salmonella, Shigella and Staphylococcus aureus ([@b20-epj-10-6548]). Hassanzadazar et al. showed growth inhibitory effects of probiotic Lactobacillus casei and Enterococcus fascium against Listeria monocytogenesis, *Escherichia coli* bacillus cereus and Salmonella enteritidis ([@b21-epj-10-6548], [@b22-epj-10-6548]). Obtained results of the present study showed growth inhibitory effects of 5 probiotic bacteria against *E. coli* O157:H7 strain. Similar studies confirmed antimicrobial effects of culture supernatant of probiotics, for example Hirano et al showed growth inhibitory effects of L. plantarum and Lactobacillus curvatus against different pathogens with well diffusion method ([@b23-epj-10-6548]). Matsusaki studied growth inhibitory effects of probiotic Lactobacillus with colony count method ([@b24-epj-10-6548]). Based on the results of this study, present probiotic bacteria in natural resources can be used for inhibition and reduction of pathogens, including enteric pathogens and antibacterial effects of their metabolites are active and stable under different conditions of temperature and acidity.
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###### 

Selected primers for polymerase chain reaction

  Primers type           Primers sequences (5′ to 3′)   Product size (bp)
  ---------------------- ------------------------------ -------------------
  Forward primer (FP1)   5′-AGAGTTTGATCATGGCTCAG-3′     20 bases
  Reverse primer (RP1)   5′-TACGGYTACCTTGTTACGACTT-3′   22 bases

###### 

Growth Inhibition zone (mm) of selected probiotic strains against 2 pathotypes of *E. coli* (Disk diffusion method)

  Probiotic              Pathogen   
  ---------------------- ---------- ----
  L.plantarum            9          \-
  L.gasseri              9          \-
  E. fascium             9          \-
  B. subtilis            12         \-
  W. paramesenteroides   10         \-

###### 

Growth Inhibition zone (mm) of selected probiotic strains against 2 pathotypes of *E. coli* (well diffusion method)

  Probiotic              Pathogen   
  ---------------------- ---------- ----
  L.plantarum            6          \-
  L.gasseri              \-         \-
  E. fascium             \-         \-
  B. subtilis            \-         \-
  W. paramesenteroides   9          \-

###### 

Growth inhibitory zone of selected antibiotics against 2 pathotypes of *E. coli* (Antibiogram)

  Antibiotic       Pathogen   
  ---------------- ---------- ----
  Nevobiocin       \-         \-
  Penicillin       \-         \-
  Nalidixic acid   22         20
  Cephalosporins   \-         \-
  Gentamycin       \-         \-
